• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Qorvo Inc. filed SEC Form 8-K: Leadership Update, Other Events, Financial Statements and Exhibits

    5/19/25 4:01:34 PM ET
    $QRVO
    Semiconductors
    Technology
    Get the next $QRVO alert in real time by email
    false 0001604778 0001604778 2025-05-16 2025-05-16 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

     

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): May 16, 2025

     

    Qorvo, Inc.

    (Exact name of Registrant as Specified in Its Charter)

     

    Delaware 001-36801 46-5288992

    (State or Other Jurisdiction

    of Incorporation)

    (Commission File Number)

    (IRS Employer

    Identification No.)

     

    7628 Thorndike Road  
    Greensboro, North Carolina   27409-9421
    (Address of Principal Executive Offices)   (Zip Code)

     

    Registrant’s Telephone Number, Including Area Code: (336) 664-1233

     

    (Former Name or Former Address, if Changed Since Last Report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class

     

    Trading

    Symbol(s)

     

    Name of each exchange on which registered

    Common Stock, par value $0.0001 per share   QRVO   The Nasdaq Stock Market LLC

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

     

    Emerging growth company ☐

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

    ITEM 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

     

    On May 16, 2025, the Board of Directors (the “Board”) of Qorvo, Inc. (the “Company”) resolved to: (i) increase the size of the Board to 10 directors; and (ii) include Peter Feld as one of the Company’s director nominees in the Company’s proxy statement for the Company’s 2025 annual meeting of stockholders (the “2025 Annual Meeting”). The Board has also resolved to recommend that the Company’s stockholders vote in favor of electing all of the Company’s director nominees, including Mr. Feld, in the Company’s proxy statement for the 2025 Annual Meeting.

     

    Once Mr. Feld is elected as a non-employee director, Mr. Feld will be compensated for his service in accordance with the Company’s director compensation program.

     

    In addition, it is expected that Mr. Feld will enter into the Company’s standard form of indemnification agreement. The form of indemnification agreement was filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K, which was filed with the Securities and Exchange Commission on January 5, 2015, and is incorporated herein by reference. The committees of the Board to which Mr. Feld would be named have not yet been determined as of the date hereof.

     

    There are no arrangements or understandings between Mr. Feld and any other persons pursuant to which Mr. Feld would be nominated or selected as a director nominee of the Board. Mr. Feld has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.

     

    ITEM 8.01. Other Events.

     

    On May 19, 2025, the Company issued a press release announcing the inclusion of Mr. Feld as one of the Company’s director nominees in the Company’s proxy statement for the 2025 Annual Meeting. The press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference.

     

    ITEM 9.01. Financial Statements and Exhibits

     

    (d) Exhibits
         
    Exhibit No.      Description
    99.1   Press release dated May 19, 2025
    104      Cover Page Interactive Data File (embedded within the Inline XBRL document)

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

          Qorvo, Inc.
           
           
    Date:  May 19, 2025 By: /s/ Grant A. Brown
          Name:     Grant A. Brown
          Title: Chief Financial Officer

     

    Get the next $QRVO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $QRVO

    DatePrice TargetRatingAnalyst
    4/30/2025$95.00Hold → Buy
    The Benchmark Company
    4/30/2025$90.00 → $80.00Hold
    TD Cowen
    1/27/2025$85.00 → $110.00Neutral → Overweight
    Piper Sandler
    1/21/2025$90.00 → $106.00Equal-Weight → Overweight
    Morgan Stanley
    11/12/2024$73.00Hold
    Loop Capital
    10/30/2024Buy → Hold
    The Benchmark Company
    10/30/2024$125.00 → $85.00Hold
    TD Cowen
    10/30/2024Outperform → Mkt Perform
    Raymond James
    More analyst ratings